医学
总体生存率
内科学
肿瘤科
前列腺
前列腺癌
生存分析
预测模型
梅德林
存活率
无进展生存期
作者
Narjess Ayati,Nathan Papa,Megan Crumbaker,Shalini Subramaniam,Anthony M Joshua,Ramin Alipour,Amir Iravani,Emran Askari,Sobia Khan,Surekha Yadav,Matthias Eiber,Andrew Weickhardt,Sze-Ting Lee,Siobhan Ng,Roslyn J Francis,Jeffrey C. Goh,David A. Pattison,Thean Hsiang Tan,Ian Kirkwood,Andrew Nguyen
出处
期刊：Radiology
[Radiological Society of North America]
日期：2026-04-01
卷期号：319 (1): e252672-e252672
被引量：1
标识
DOI：10.1148/radiol.252672
摘要
Lutetium 177 prostate-specific membrane antigen–617 SPECT/CT total tumor volume complete response at 6 weeks was associated with overall survival and may help guide early personalized treatment decisions in metastatic castration-resistant prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
张欢馨
东方元语
馆长
cdercder
Kao
OK
扎心
糊涂的灯泡
aajhajkahna
xing_xing
yz
学术文献互助
xwyuy
whisper
Criminology34
LYK
初景
pluto
七听
皖公网安备34019202002308
